We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LILM
13101
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$8.35K ﹤0.01%
11,706
+8,521
+268% +$9.96K
GCTK icon
13102
GlucoTrack
GCTK
$2.84M
$8.34K ﹤0.01%
+5
New +$8.98K
ETON icon
13103
PUT
Eton Pharmaceutcials
ETON
$1.68B
$8.34K ﹤0.01%
2,000
+900
+82% +$3.47K
APYX icon
13104
CALL
Apyx Medical
APYX
$128M
$8.32K ﹤0.01%
2,600
-18,800
-88% -$87.6K
APYX icon
13105
PUT
Apyx Medical
APYX
$128M
$8.32K ﹤0.01%
2,600
+700
+37% +$3.26K
MBIN icon
13106
CALL
Merchants Bancorp
MBIN
$2.52B
$8.32K ﹤0.01%
300
+100
+50% +$2.89K
VBIV
13107
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$8.3K ﹤0.01%
+12,458
New +$15.3K
QBTS icon
13108
PUT
D-Wave Quantum Inc
QBTS
$7.88B
$8.3K ﹤0.01%
8,600
-16,300
-65% -$26K
RNAM
13109
PUT
DELISTED
Avidity Biosciences
RNAM
$8.29K ﹤0.01%
1,300
-17,300
-93% -$149K
ARKX icon
13110
CALL
ARK Space & Defense Innovation ETF
ARKX
$865M
$8.27K ﹤0.01%
600
-6,400
-91% -$93.5K
HOOK
13111
CALL
DELISTED
HOOKIPA Pharma
HOOK
$8.25K ﹤0.01%
1,340
– –
UPH
13112
DELISTED
UpHealth, Inc.
UPH
$8.25K ﹤0.01%
+8,416
New +$12.3K
WNW icon
13113
Meiwu Technology Co
WNW
$67.4M
$8.24K ﹤0.01%
+1
New +$10.8K
IMMP
13114
Immutep
IMMP
$56M
$8.23K ﹤0.01%
4,332
-4,190
-49% -$8.5K
KB icon
13115
CALL
KB Financial Group
KB
$42.1B
$8.22K ﹤0.01%
200
-22,000
-99% -$872K
WWR icon
13116
PUT
Westwater Resources
WWR
$72.7M
$8.21K ﹤0.01%
12,300
+100
+0.8% +$76
FTK icon
13117
CALL
Flotek Industries
FTK
$1.3B
$8.21K ﹤0.01%
1,853
+586
+46% +$2.78K
ATXS
13118
PUT
DELISTED
Astria Therapeutics
ATXS
$8.21K ﹤0.01%
1,100
-4,400
-80% -$37.5K
NTWK icon
13119
CALL
NetSol Technologies
NTWK
$48.3M
$8.19K ﹤0.01%
4,500
+1,900
+73% +$4.24K
SSL icon
13120
Sasol
SSL
$7.39B
$8.19K ﹤0.01%
599
-43,742
-99% -$574K
HGTY icon
13121
PUT
Hagerty
HGTY
$1.32B
$8.17K ﹤0.01%
1,000
+900
+900% +$7.89K
DSI icon
13122
PUT
iShares MSCI KLD 400 Social ETF
DSI
$5.58B
$8.14K ﹤0.01%
+100
New +$8.48K
HBIO icon
13123
Harvard Bioscience
HBIO
$30.3M
$8.13K ﹤0.01%
189
-188
-50% -$8.68K
SLGC
13124
PUT
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$8.13K ﹤0.01%
3,400
-3,300
-49% -$7.31K
CGRN
13125
CALL
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$8.08K ﹤0.01%
11,400
– –
523 524
525
526 527

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.